Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2878 of 5804
-
Experimental vaccine combo for rare adrenal cancers shows early promise but trial halted
Disease control TerminatedThis is a multicenter, Phase 1/2, First-In-Human study to assess the safety, tolerability, immunogenicity, and preliminary efficacy of EO2401 in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma.
Phase: PHASE1, PHASE2 • Sponsor: Enterome • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Lymphoma drug duvelisib tested after transplant – trial ends early
Disease control TerminatedThe investigators hypothesize that duvelisib maintenance after autologous stem cell transplant in patients with T-cell lymphomas will be safe and well tolerated, and will improve progression free survival.
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Uterus-Saving surgery showdown: which fix works best for pelvic organ prolapse?
Disease control CompletedThe investigators present a literature review evaluating the current place of sacrospinous hysteropexy in the surgical management of pelvic organ prolapse. Additionally, to assess the efficacy of the procedure, the investigators performed a meta-analysis comparing sacrospinous hy…
Sponsor: Hillel Yaffe Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Virtual reality could revolutionize ADHD diagnosis in kids
Diagnosis CompletedThe aim of this study is to develop an application in order to identify the most relevant cognitive and behavioral parameters for the diagnosis of Attention Deficit Hyperactivity Disorder (ADHD) in conditions closer to reality
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Diagnosis
Last updated Jun 27, 2026 12:35 UTC
-
Sound waves may help deliver brain tumor drug
Disease control CompletedThis is a prospective, single-arm, two stages, open-label, pilot study to investigate the efficacy and safety of FUS add-on bevacizumab (BEV) in rGBM patients. The BEV is the best physician's choice of standard of care for rGBM after prior radiotherapy and temozolomide chemothera…
Phase: NA • Sponsor: NaviFUS Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New study looks inside the womb to see how opioid medications impact unborn babies
Knowledge-focused CompletedThis is a sub-study of NIDA CTN Protocol 0080: Medication Treatment for Opioid Use Disorder in Expectant Mothers (MOMs; Unique protocol ID: 2019-0429-1). Participants in MOMs will be offered the opportunity to enroll in this sub-study, which is designed to evaluate conceptual mod…
Sponsor: T. John Winhusen, PhD • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Could tai chi soothe stubborn gut troubles?
Symptom relief CompletedThe purpose of the study is to evaluate the efficacy of Tai Chi practice in reducing symptoms of Irritable Bowel Syndrome with Constipation (IBS-C).
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New program aims to keep girls in school and out of child labor
Prevention CompletedThe primary goal of this pilot study (R21) is to address the urgent need for theoretically and empirically informed interventions that prevent poor female youth's rural-to-urban migration for child labor in low and middle-income countries. The study will address the following spe…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Prevention
Last updated Jun 27, 2026 09:04 UTC
-
Online therapy cuts stress for COVID-19 health workers
Symptom relief CompletedSome preliminary epidemiological research conduct in China in health workers involved in the care of Covid-19 patients has shown high rates of depression (\>50%), generalized anxiety disorder (\>44%), insomnia (\>36%) and stress symptoms (\>73%), which negatively impact their wel…
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
Experimental pill aims to tame deadly inflammation in severe COVID
Disease control CompletedPrimary Objective: To evaluate the effect of SAR443122 relative to the control arm on the hyperinflammatory state as measured by C-reactive protein (CRP) levels in adult patients hospitalized with severe coronavirus disease 2019 (COVID-19) Secondary Objectives: * To evaluate t…
Phase: PHASE1 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
DNA test could Fine-Tune blood thinners for heart patients
Knowledge-focused OngoingThe feasibility and clinical benefit of using a patient's genotype to guide antiplatelet therapy prescribing has been demonstrated. However, a more precise understanding of who to genotype, what to include on a genetic testing panel, and how to change antiplatelet therapy based o…
Sponsor: University of Florida • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Radiation implants take aim at inoperable kidney cancers
Disease control Recruiting nowThis phase I/II trial investigates the side effects of interstitial brachytherapy and to see how well it works in limiting the growth of large kidney cancer masses in patients with kidney cancer that have refused or are unable to undergo surgery or ablation (unresectable/unablata…
Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Nasal spray test could make allergy shots smarter and cheaper
Knowledge-focused Recruiting nowThis prospective multicentric academic NAPT study aims to compile a database of all patients who initiate immunotherapy. The NAPT will take place before, during and after AIT to evaluate the cost and effectiveness of the treatment. The study consists of 4 visits and 2 telephone …
Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Scientists investigate key immune cells in severe drug allergy
Knowledge-focused Recruiting nowDrug Hypersensitivity Syndrome or DRESS for "Drug Reaction with Eosinophilia and Systemic Symptoms" is a serious drug allergy which can be life-threatening for patients with serious organ damage. The pathophysiology of DRESS is still not fully understood. In particular, no study …
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Shock therapy for sex? nerve zaps may help premature ejaculation
Disease control CompletedObjective: Evaluate the effectiveness and safety of transcutaneous electrostimulation of the posterior tibial nerve alone and combined with standard pharmacological treatment, in men with primary premature ejaculation, compared to standard pharmacological treatment. Patients and…
Phase: NA • Sponsor: Boston Medical Group • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New Immune-Boosting drug takes on Hard-to-Treat cancers
Disease control Recruiting nowTTX-080-001 is a Phase 1, open label, dose escalation and dose expansion clinical study to determine the safety, tolerability, and recommended Phase 2 dose of TTX-080 monotherapy (HLA-G inhibitor) and in combination with either pembrolizumab (PD-1 inhibitor), cetuximab (EGFR inhi…
Phase: PHASE1 • Sponsor: Tizona Therapeutics, Inc • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New drug combo shows promise against tough cancers
Disease control CompletedThe purpose of this study is to evaluate BMS-986315 alone and in combination with nivolumab or cetuximab in participants with advanced solid tumors.
Phase: PHASE1, PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Win prizes, lower blood pressure: smartphone lottery boosts medication adherence
Disease control CompletedBETTER-BP (Behavioral Economics Trial To Enhance Regulation of Blood Pressure) is a phase II, single-center, prospective, pragmatic randomized clinical trial within the New York City Health and Hospitals (NYC-H+H) system and NYU Langone Family Health Centers. The trial will recru…
Phase: NA • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Spinal fluid test may forecast MS severity
Knowledge-focused Recruiting nowMultiple sclerosis (MS) is a chronic inflammatory autoimmune disease of the central nervous system, usually presenting as clinically isolated syndrome (CIS). The course of MS following first symptoms is unpredictable, as approximately 30% of patients with MS have a benign course …
Sponsor: Francis Corazza • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
New PET tracer could spot hidden heart inflammation
Diagnosis CompletedInfectious myocarditis are frequent, most of the time viral and can evolve to cardiac insufficiency. The diagnosis is difficult because they can mime an acute coronary syndrome. Approximately 10 % of patients with acute infarction suspected, have a normal angiography, and half of…
Phase: NA • Sponsor: Central Hospital, Nancy, France • Aim: Diagnosis
Last updated Jun 27, 2026 14:03 UTC